World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
106
Citations
48887
World Ranking
6441
National Ranking
3425

Marwan N. Sabbagh publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Marwan N. Sabbagh sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 555 publications — 66th percentile

66% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Marwan N. Sabbagh D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Marwan N. Sabbagh sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 106 D-Index — 69th percentile

69% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Marwan N. Sabbagh is affiliated with the Lou Ruvo Brain Institute in the United States. Their research primarily focuses on medicine, with specific contributions in psychiatry and mental health, physiology, neurology, radiology, nuclear medicine and imaging, as well as public health, environmental and occupational health.

The scientist's main fields of study encompass various aspects of neurodegenerative diseases and cognitive disorders. Key topics in their work include:

  • Dementia and Cognitive Impairment Research
  • Alzheimer's disease research and treatments
  • Cholinesterase and Neurodegenerative Diseases
  • Health, Environment, Cognitive Aging
  • Frailty in Older Adults
  • Down syndrome and intellectual disability research
  • Health Systems, Economic Evaluations, Quality of Life

Marwan N. Sabbagh has contributed to multiple peer-reviewed publications. Recent selected papers include:

  • "Diagnosis of Early Alzheimer's Disease: Clinical Practice in 2021" (2021), The Journal of Prevention of Alzheimer s Disease
  • "Alzheimer's disease drug development pipeline: 2020" (2020), Alzheimer s & Dementia Translational Research & Clinical Interventions
  • "Aducanumab, gantenerumab, BAN2401, and ALZ-801-the first wave of amyloid-targeting drugs for Alzheimer's disease with potential for near term approval" (2020), Alzheimer s Research & Therapy
  • "Practical recommendations for timely, accurate diagnosis of symptomatic Alzheimer's disease (MCI and dementia) in primary care: a review and synthesis" (2021), Journal of Internal Medicine
  • "Aducanumab produced a clinically meaningful benefit in association with amyloid lowering" (2021), Alzheimer s Research & Therapy

Their frequent co-authors reflect collaborative research efforts in related fields and include:

  • Jeffrey L. Cummings
  • Boris Decourt
  • Aaron Ritter
  • Eric M. Reiman
  • Anna Burke

Marwan N. Sabbagh's publications appear regularly in established venues focused on dementia and Alzheimer's disease research, such as:

  • Alzheimer s & Dementia
  • The Journal of Prevention of Alzheimer s Disease
  • Alzheimer s Research & Therapy
  • Alzheimer s & Dementia Translational Research & Clinical Interventions
  • Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring

Best Publications

  • Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease

    Stephen Salloway;Reisa Sperling;Nick C. Fox;Kaj Blennow

  • Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins

    Sandip Ray;Markus Britschgi;Charles Herbert;Yoshiko Takeda-Uchimura

  • Use of Florbetapir-PET for Imaging β-Amyloid Pathology

    Christopher M. Clark;Julie A. Schneider;Barry J. Bedell;Thomas G. Beach

  • Early role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysis

    Y. Iturria-Medina;R. C. Sotero;P. J. Toussaint;J. M. Mateos-Pérez

  • Multi-organ distribution of phosphorylated α-synuclein histopathology in subjects with Lewy body disorders

    Thomas G. Beach;Charles H. Adler;Lucia I. Sue;Linda Vedders

  • Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group.

    Bruno Dubois;Nicolas Villain;Giovanni B. Frisoni;Gil D. Rabinovici

  • Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study

    Christopher M Clark;Michael J Pontecorvo;Thomas G Beach;Barry J Bedell

  • A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease.

    S. Salloway;R. Sperling;S. Gilman;N.C.I. Fox

  • Unified Staging System for Lewy Body Disorders: Correlation with Nigrostriatal Degeneration, Cognitive Impairment and Motor Dysfunction

    Thomas G. Beach;Charles H. Adler;LihFen F. Lue;Lucia I. Sue

  • Four distinct trajectories of tau deposition identified in Alzheimer’s disease

    Jacob W Vogel;Alexandra L Young;Neil P Oxtoby;Ruben Smith

  • Alzheimer's disease drug development pipeline: 2019.

    Jeffrey Cummings;Jeffrey Cummings;Garam Lee;Aaron Ritter;Marwan Sabbagh

  • Amyloid β peptide load is correlated with increased β-secretase activity in sporadic Alzheimer's disease patients

    Rena Li;Kristina Lindholm;Li-Bang Yang;Xu Yue

  • Longitudinal Modeling of Age-Related Memory Decline and the APOE ε4 Effect

    Richard J. Caselli;Amylou C. Dueck;David Osborne;Marwan N. Sabbagh

  • Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: Phase 3 study

    Osama Sabri;Marwan N. Sabbagh;John Seibyl;Henryk Barthel

  • Defining mild cognitive impairment in Parkinson's disease.

    John Nathaniel Caviness;Erika M Driver-Dunckley;Donald J. Connor;Marwan N. Sabbagh

  • Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results.

    D. Larry Sparks;Marwan N. Sabbagh;Donald J. Connor;Jean Lopez

  • Why do trials for Alzheimer's disease drugs keep failing? A discontinued drug perspective for 2010-2015.

    Dev Mehta;Robert Jackson;Gaurav Paul;Jiong Shi

  • New acetylcholinesterase inhibitors for Alzheimer's disease.

    Mona Mehta;Abdu Adem;Marwan Sabbagh

  • Low clinical diagnostic accuracy of early vs advanced Parkinson disease: Clinicopathologic study

    Charles H. Adler;Thomas G. Beach;Joseph G. Hentz;Holly A. Shill

  • Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis

    Reisa Sperling;Stephen Salloway;David J Brooks;Donatella Tampieri

Frequent Co-Authors

Charles H. Adler
Charles H. Adler Mayo Clinic
Thomas G. Beach
Thomas G. Beach Banner Health
Holly A. Shill
Holly A. Shill Barrow Neurological Institute
John N. Caviness
John N. Caviness Mayo Clinic
Douglas G. Walker
Douglas G. Walker Arizona State University
Eric M. Reiman
Eric M. Reiman Arizona State University
Mark A. Mintun
Mark A. Mintun University of Pennsylvania
Alex E. Roher
Alex E. Roher Banner Health
Stephen Salloway
Stephen Salloway Brown University
Reisa A. Sperling
Reisa A. Sperling Brigham and Women's Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those pursuing a medical career in the USA, a range of related online degree programs and alternative pathways can help accelerate your goals or expand your expertise. Many students and professionals now consider programs that offer flexibility, affordability, and quicker routes to professional roles in healthcare.

If you are looking to become a registered nurse or advance your career, exploring an lpn fast track program is an excellent way to enter nursing quickly and efficiently. For those aiming for leadership roles in advanced practice nursing, several affordable dnp programs are available online, making it possible to earn a doctoral degree without high financial barriers.

Mental health is a fast-growing field; if you’re interested in this area, an msn to pmhnp online program can prepare you for specialized practice as a psychiatric mental health nurse practitioner. Alternatively, those desiring a broader administrative or managerial role in healthcare may benefit from pursuing an online health management degree for career advancement.

Best Scientists Citing Marwan N. Sabbagh

Trending Scientists

Recently Published Articles